Pediatric rheumatology

Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases

Clin Exp RheumatolPublished Cross-sectional study

Authors' conclusion

NVC is a valuable tool for differentiating pRP from early juvenile CTDs and may help risk stratification for organ involvement, particularly ILD.

Study context

Population
Children with pRP and juvenile connective tissue diseases (CTDs) (juvenile systemic sclerosis (JSSc), JDM, JSLE), regardless of RP status, followed at a Paediatric Rheumatology Unit
Participants
50 children1,600 nailfold videocapillaroscopy (NVC) images
Exposure
NVC findings in pRP vs juvenile CTDs
Outcome
NVC findings (non-specific or scleroderma pattern; six capillary abnormalities) and their associations with clinical/organ involvement
Methodological detailstwo independent observers, semiquantitative rating scale
  • Two independent observers
  • Semiquantitative rating scale

Main finding

As reported in the abstract

  • Differences in capillaroscopic alterations observed only between pRP and JSSc
  • JSSc vs pRP: P < 0.001
  • JSSc vs JDM: P < 0.005
  • JSSc vs pRP: P < 0.001
  • JSSc vs pRP: P = 0.01

Observational data: associations, not effects.

Further findings

OutcomeILDNo ILDEstimateP value
Skin fibrosis, scleroderma pattern vs notproportion 21/25 vs. 0/9P < 0.001
Gastrointestinal involvement, scleroderma pattern vs notproportion 17/25 vs. 1/9P = 0.006
Digital ulcers, scleroderma pattern vs notTrend towards significanceproportion 8/25 vs. 0/9P = 0.07
Avascular score, ILD vs no ILDSignificantly higher in ILD0.69 ± 0.510.44 ± 0.38P = 0.048
ILD with severe reduction of capillary density (≤4 capillaries/mm) vs notproportion with ILD 5/10 vs. 4/13P = 0.02

Original publication

Nailfold videocapillaroscopy in the assessment of juvenile connective tissue diseases. Clin Exp Rheumatol. Published 26 August 2025. doi:10.55563/clinexprheumatol/6bz7ok

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.